The event featured a combination of expert-led didactic lectures and live case observations, providing participating physicians from across Asia with critical insights into clinical applications and techniques. By focusing on both theoretical knowledge and practical application, the Masterclass reinforced the importance of precision in clinical practice and facilitated the exchange of advanced methodology among regional specialists. This initiative highlights Baird Medical's enduring commitment to physicia ...

Core Insights - Baird Medical Investment Holdings Ltd. is a leader in minimally invasive Microwave Ablation (MWA) technology and successfully participated in the 44th Annual J.P. Morgan Healthcare Conference [1] Group 1: Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments [4] - The company aims to enhance patient outcomes through precision technology and advanced diagnostic solutions, and has established partnerships with leading academic institutions [4] - Baird Medical is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics across the U.S., including Mayo Clinic and UCSF Medical Center [4] - The company is also a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [4] Group 2: Strategic Focus - During the J.P. Morgan Healthcare Conference, Baird Medical's leadership discussed the company's 2026 strategic priorities, emphasizing the acceleration of its U.S. commercial footprint and the adoption of thyroid ablation technologies [2] - The U.S. CEO, Mark Saxton, highlighted the market's interest in Baird Medical's differentiated MWA platform and the company's commitment to driving clinical excellence and sustainable growth [3] - Following the conference, Baird Medical remains focused on executing its operational roadmap to enhance shareholder value and expand patient access to its minimally invasive solutions [3]

Core Insights - The company has successfully launched its product in Pakistan at the Armed Forces Institute of Radiology & Imaging, guided by Dr. Raza Raheem, a key figure in interventional radiology [1] - The registration approval in Vietnam signifies a major expansion of Baird Medical's presence in the Southeast Asian market, highlighting the company's commitment to global commercialization [2][3] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments [3] - The company aims to enhance patient outcomes through precision technology and advanced diagnostic solutions, and plans to collaborate with leading academic institutions [3] - Baird Medical is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals in the U.S., including Mayo Clinic and UCSF Medical Center [3] - The company is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries [3]

Core Insights - Baird Medical Investment Holdings Ltd. has appointed Mark Saxton as the new CEO of its U.S. subsidiary, aiming to enhance its market presence in the U.S. [1] - Saxton brings over 25 years of experience in the medical device industry, particularly in intravascular RF ablation technologies, and has a history of driving significant revenue growth and successful exits for medtech companies [1] - The company is focused on advancing its Microwave Ablation technology, which offers advantages in minimally invasive care, and aims to expand access for patients while creating shareholder value [1] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, with a commitment to research and development of surgical robotic systems and innovative surgical instruments [1] - The company is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics in the U.S., including Mayo Clinic and UCSF Medical Center [1] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [1]

Core Insights - Baird Medical Investment Holdings Ltd. has officially launched its Microwave Ablation (MWA) technology in the Egyptian market with a successful procedure at Ain Shams Specialized Hospital [1][2][3] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments [3] - The company is FDA 510(k)-certified and has a presence in over 30 prestigious hospitals in the United States, including Johns Hopkins Hospital and Columbia University Medical Center [3] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [3] Recent Developments - The first procedure in Egypt involved a bone ablation for a 30-year-old male patient, successfully achieving full ablation and significant pain relief [2] - This procedure demonstrates the versatility of Baird's MWA system, extending its application from soft tissue to musculoskeletal treatments [2][3] - The company aims to enhance global access to advanced, non-surgical solutions through strategic partnerships with leading academic institutions [3]

Core Insights - Baird Medical Investment Holdings Ltd. has announced the clinical adoption of its Microwave Ablation (MWA) system at Elk Medical, a private endocrinology practice in Brooklyn, New York, marking a significant step in expanding access to minimally invasive thyroid treatments [1][3] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments, with a mission to enhance patient outcomes through precision technology [4] - The company is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics across the United States, including Johns Hopkins Hospital and Columbia University Medical Center [4] - Baird Medical is a market leader in China for thyroid microwave ablation devices and consumables, and is expanding its commercial presence in over 20 countries worldwide [4] Clinical Adoption and Economic Viability - Dr. Kazeem, an experienced endocrinologist, has performed nine MWA procedures recently, focusing on large thyroid nodules as a non-surgical treatment option [2] - The initial MWA procedures have been successfully reimbursed by Medicare, indicating potential for broader patient access and economic viability of MWA therapy [3]

Core Insights - Baird Medical Investment Holdings Ltd. has successfully completed its first Microwave Ablation (MWA) procedure in Bangladesh, marking a significant advancement in non-surgical cancer therapies in the region [1][2][3] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on the research and development of surgical robotic systems and innovative surgical instruments [4] - The company is FDA 510(k)-certified and has its solutions utilized in over 30 prestigious hospitals and clinics across the United States, including Johns Hopkins Hospital and Weill Cornell Medicine [4] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [4] Recent Developments - The first MWA procedure in Bangladesh was led by Dr. Mofazzal Sharif Rasel, successfully treating a 65-year-old patient with a 6 cm liver tumor, who is reported to be recovering well [2][3] - The completion of this procedure signifies a new era of access to advanced treatment options for patients in South Asia, reflecting growing global confidence in Baird Medical's MWA technology [3] Strategic Goals - Baird Medical aims to strengthen its global presence through strategic collaborations with leading clinicians and medical institutions, enhancing access to innovative tumor treatment solutions [3]

Core Insights - Baird Medical Investment Holdings Ltd. is a global leader in minimally invasive Microwave Ablation (MWA) technology and has successfully participated in a workshop in Malaysia aimed at advancing MWA skills among local physicians [1][3]. Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments [4]. - The company is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics in the United States, including Johns Hopkins Hospital and Weill Cornell Medicine [4]. - Baird Medical is the market leader in China for thyroid microwave ablation devices and consumables, with a growing commercial presence in over 20 countries [4]. Workshop Details - The workshop held on October 1-2, 2025, featured leading surgeons and endocrinologists, providing hands-on training and complex case discussions [2]. - The program was led by distinguished faculty, including Dr. Shuhang Xu from Nanjing University and local surgeons from HCTM [2]. Commitment to Innovation - Baird Medical's participation in the workshop underscores its commitment to advancing medical technologies and ensuring their effective adoption globally [3]. - The company aims to empower physicians to deliver MWA treatments safely and effectively, marking a significant step in the global expansion of this therapy [3].

Core Insights - Baird Medical Investment Holdings Ltd. participated in the 3rd International Workshop on Thermal Ablation of Thyroid Tumor and Hyperparathyroidism, highlighting its leadership in minimally invasive Microwave Ablation (MWA) technology [1][3][4] - The workshop, chaired by Prof. Ming'an Yu, served as a platform for experts to share clinical experiences and advanced techniques in the field [2] - Baird Medical emphasizes the importance of collaboration in advancing MWA innovation and improving patient care [4] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments [6] - The company is FDA 510(k)-certified and has its solutions utilized in over 30 prestigious hospitals in the U.S., including Johns Hopkins Hospital and Columbia University Medical Center [6] - Baird Medical is the market leader in China for thyroid microwave ablation devices and is expanding its presence in over 20 countries [6]

Core Insights - Baird Medical Investment Holdings Ltd. is participating in the American College of Surgeons Clinical Congress 2025, showcasing its minimally invasive Microwave Ablation technology [1][4] - The ACS is the largest organization for surgeons globally, with over 90,000 members, providing a platform for discussing surgical advancements [2] - Baird Medical is conducting live demonstrations of its MWA devices, highlighting their precision in treating conditions like thyroid nodules and liver cancer [3][4] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative instruments [5] - The company is FDA 510(k)-certified and has its solutions used in over 30 prestigious hospitals in the U.S., including Johns Hopkins and Weill Cornell Medicine [5] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its presence in over 20 countries [5]